SAfeguarding female FERtility -development of human-relevant in vitro tools for reproductive toxicity

SAFER aims to develop innovative, animal-free assays for assessing reproductive toxicity in women, using advanced technologies to identify harmful chemicals and promote safer environments.

Subsidie
€ 2.000.000
2024

Projectdetails

Introduction

Chemical health risk assessment has failed to safeguard fertility in women. Women and their oocytes are exposed to pervasive mixtures of human-made chemicals that correlate with reproductive ageing and infertility. Only 0.5% of the chemicals on the European market have been well characterized for health risks, and reproductive toxicity in women is typically not covered due to missing tools.

European Growth Strategy

The new European Growth Strategy aims at sustainable growth, zero-pollution, and safe chemicals. While the need for increased chemical testing is tangible, there is a movement to phase out animal experiments. This creates a huge challenge to deliver on the vision of a safe and toxic-free environment.

Project Overview

Here, I will develop new high-content assays for reproductive toxicity in women. SAFER is built on my exceptional ovary biobank, established stem cell lines, and multi-omics technologies.

Methodology

Using chemically exposed ovarian tissue and stem cell-derived blastoid cultures, SAFER will map mechanisms mediating toxicity by high-resolution epigenetic and transcriptomic analyses. Model chemicals are chosen based on:

  1. Ubiquitous presence in women
  2. Significant associations to decreased ovarian function, as shown by my cohort studies.

The identified mechanisms will be tailored into reporter genes that I will insert into new immortalized human ovarian cells as well as stem cells, and develop into high-content screening assays. The product of SAFER is novel in vitro tools for screening of female reproductive toxicants.

Impact

Taken together, SAFER sets an example for animal-free derivation of assays for chemical safety assessment. SAFER tools will contribute to the identification and restriction of chemicals that pose a hazard to women’s health. This is an important step in the global movement towards a non-toxic, safe environment.

Conclusion

Starting a family is a basic human right, and whether to have a child or not should be decided by the prospective parents, not by the chemicals in their environment.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.000.000
Totale projectbegroting€ 2.000.000

Tijdlijn

Startdatum1-10-2024
Einddatum30-9-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • KAROLINSKA INSTITUTETpenvoerder

Land(en)

Sweden

Vergelijkbare projecten binnen European Research Council

ERC Proof of...

Developing a human-based stem cell model for reproductive toxicity

Developing a high-throughput human-based assay for male reproductive toxicity to enhance drug safety testing and reduce reliance on animal models.

€ 150.000
ERC Proof of...

Human blastoids: a drug discovery platform for women’s reproductive health

BLASTOID-DISCOVERY aims to utilize human blastoids as a scalable and ethical model for drug discovery to enhance women's reproductive health and reduce development costs.

€ 150.000
ERC Starting...

Representative, Reliable and Reproducible in vitro Models of the Human Testes

The project aims to develop a reliable preclinical model of human testes using tailored hydrogels to improve male infertility treatments through high-throughput experimentation and automated analysis.

€ 1.499.980
ERC Consolid...

dAta-dRiven integrated approaches to CHemIcal safety assessMEnt and Drug dEvelopment

The ARCHIMEDES project aims to revolutionize chemical and drug development by integrating toxicogenomics, AI, and a Knowledge Graph to enhance safety and innovation in a regulatory-compliant manner.

€ 2.000.000
ERC Consolid...

Molecular mechanisms through which oocytes evade ageing

This project aims to uncover the molecular mechanisms that allow dormant oocytes to maintain cellular fitness and how these mechanisms fail with age, enhancing understanding of female fertility and ageing.

€ 1.999.796

Vergelijkbare projecten uit andere regelingen

EIC Transition

Cultivating hope one star sperm at a time

Spermotile aims to revolutionize male infertility treatment by providing an automated, AI-driven sperm selection platform that enhances ART success rates and reduces costs for clinics and patients.

€ 2.499.906
Mkb-innovati...

Fusion of Ecological protection and stimulation of crops

I am BioTech onderzoekt biologische oplossingen om de negatieve impact van traditionele meststoffen en bestrijdingsmiddelen op het ecosysteem te verminderen.

€ 20.000
LIFE Standar...

LIFE Chemical Ambassadors for Europe

LIFE ChemBee aims to empower consumers to change purchasing behaviors through the Household Check tool, increasing awareness of harmful substances and reducing emissions in 43,000 households across Europe.

€ 1.199.786
EIC Accelerator

Multi-organ toxicity and efficacy test platform for Personalized medicine & Drug development

Cherry Biotech aims to revolutionize drug development and personalized medicine by providing a patented 3D cell culture platform that enhances predictability and reduces reliance on animal testing.

€ 2.499.831
LIFE Standar...

Awareness raising and behaviour change program to empower consumer-citizens to live toxic-free lives, reduce chemical risks on their health and the environment, and to upscale their positive impact

The project aims to raise awareness and drive behavior change regarding harmful chemicals in consumer goods in the CEE region, mobilizing citizens and influencing policy for safer alternatives.

€ 1.199.134